The industry faces the challenge of efficiently producing large quantities of therapeutic proteins to meet growing demand and reduce manufacturing costs. Expectations for mammalian cell production are increasing each year, with efforts focused on enhancing host cells and optimizing cell culture media to achieve high yields, with product titers reaching 10 g/L.Recombinant Insulin is essential in chemically defined media to increase cell proliferation and boost productivity of CHO cells.
Where can I learn more?
For more information visit our case study about optimizing CHO-K1 fed-batch cell culture medium for mAb production.
